Senator Patrick Leahy (D-VT) has announced that he won’t be seeking re-election to the Senate for a ninth term. First elected in 1974, Senator Leahy has spent nearly 50 years in the Senate, focused on a wide variety of issues. Intellectual property is one of those issues, and it’s an issue where he’s been a…
Tag Archive for America Invents Act
Leahy and Cornyn Introduce Bill To Restore The America Invents Act
by Josh Landau •
Yesterday, Senate Judiciary IP Subcommittee Chair Sen. Leahy (D-VT) and committee member Sen. Cornyn (R-TX) introduced the Restoring the America Invents Act (RAIA). RAIA would roll back changes introduced by former USPTO Director Andrei Iancu and by the courts, restoring the America Invents Act (AIA) to what it was always intended to be—a cost-effective alternative…
Arthrex Is Here—What Will It Mean?
by Josh Landau •
Yesterday, the Supreme Court handed down its much-awaited decision—at least, much-awaited by people who care about patents and the Patent Trial and Appeal Board (PTAB)—in the consolidated U.S. v Arthrex, Arthrex v. Smith & Nephew, and Smith & Nephew v. Arthrex cases. And while the multiple parties and multiple opinions might look complicated, it’s actually…
Senator Leahy to Take Chair of IP Subcommittee
by Josh Landau •
I’ve been informed that, contrary to what many expected, Senator Leahy will be taking over the Chair of the Senate Judiciary Subcommittee on Intellectual Property, with Senator Coons moving to a newly reconstituted Privacy, Technology, and the Law Subcommittee. Senator Leahy was one of the authors of the 2011 America Invents Act (AIA), and may…
Additional Studies Show IPR Is Not A Threat To Hatch-Waxman Process
by Josh Landau •
Over a year ago, I took a look at a study of the success rate for inter partes reviews (IPRs) of pharmaceutical patents. That study showed that drug and biologic patents are significantly more likely to be upheld at the PTAB than the average patent. Recently, there’s been a wave of additional studies looking at…
CAFC Determines No Requirement To Reopen Non-Instituted Claims Post-SAS
by Josh Landau •
While the Supreme Court continues to consider WesternGeco, that’s not the only oil services patent case to read up on.1 A little over a month ago, the Supreme Court’s SAS opinion determined that the PTAB can’t pick and choose which claims to consider in an inter partes review (IPR). Today, the Federal Circuit released its…
Chabot, Johnson Introduce House Fee-Setting Reauthorization Bill
by Josh Landau •
Back in March, Senator Coons and Senator Hatch introduced a bill to renew the USPTO’s authorization to set its own fees, the “BIG Data for IP” Act (S. 2601). This week, Reps. Chabot (OH) and Johnson (GA) introduced a House companion bill (H.R. 5887). As I wrote back in March, fee-setting authority is critical…
A Little More Than Forty Percent: Outcomes At The PTAB, District Court, and the EPO
by Josh Landau •
In the run-up to Oil States, a frequent criticism by opponents of patent reform was that the PTAB was “unfair” and that it invalidated patents at a rate far higher than the district courts would if they had the chance. Unfortunately this is contradicted by the actual facts, which is something we’ve seen before…
PTAB Will Continue To Double-Check Its Work—All Of It
by Josh Landau •
Today, the Supreme Court issued two opinions in cases focused on the inter partes review (IPR) procedure. First, in Oil States v. Greene’s Energy Group, the Court upheld the constitutionality of IPR by a 7-2 vote. Second, in a more narrowly divided 5-4 decision in SAS v. Matal, the Court decided that the PTAB’s practice…
The Patent Examination Process Shouldn’t Be An Oversight
by Josh Landau •
Director Iancu will be appearing for his first oversight hearing tomorrow, Wednesday, April 18. This follows on his recent speech at the Chamber of Commerce, at which he emphasized two areas of focus: Patent rights should be more predictable and the system should be more stable. When discussing the patent system, dialogue should be more…